Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes

Blood

Volumn 118, Issue 7, 2011, Pages 1923-1933

  Tham, Wai Hong ^a,b   Schmidt, Christoph Q ^c   Hauhart, Richard E ^d   Guariento, Mara ^c   Tetteh Quarcoo, Patience B ^c,e   Lopaticki, Sash ^a   Atkinson, John P ^d   Barlow, Paul N ^c   Cowman, Alan F ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF GHANA   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BINDING PROTEIN; CELL PROTEIN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT CONTROL PROTEIN 1; COMPLEMENT CONTROL PROTEIN 2; COMPLEMENT CONTROL PROTEIN 3; RETICULOCYTE BINDING LIKE HOMOLOG PROTEIN 4; SIALIC ACID; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; ERYTHROCYTE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

EID: 80051905678     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-03-341305     Document Type: Article

References (50)

1. Hourcade D., Holers V.M., Atkinson J.P. The regulators of complement activation (RCA) gene cluster. Adv Immunol. 1989;45:381-416. (Pubitemid 19195511)
2. Dörig R.E., Marcil A., Chopra A., Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 1993;75(2):295-305. (Pubitemid 23320293)
3. Nemerow G.R., Wolfert R., McNaughton M.E., Cooper N.R. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol. 1985;55(2):347-351. (Pubitemid 16239720)
4. Speth C., Kacani L., Dierich M.P. Complement receptors in HIV infection. Immunol Rev. 1997;159:49-67. (Pubitemid 27499859)
5. Schorey J.S., Carroll M.C., Brown E.J. A macrophage invasion mechanism of pathogenic mycobacteria. Science. 1997;277(5329):1091-1093. (Pubitemid 27371629)
6. Domínguez M., Torano A. Immune adherence-mediated opsonophagocytosis: The mechanism of Leishmania infection. J Exp Med. 1999;189(1):25-35. (Pubitemid 29047024)
7. Spadafora C., Awandare G.A., Kopydlowski K.M., et al. Complement receptor 1 is a sialic acidindependent erythrocyte receptor of Plasmodium falciparum. PLoS Pathog. 2010;6(6):e1000968.
8. Tham W.H., Wilson D.W., Lopaticki S., et al. Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc Natl Acad Sci U S A. 2010;107(40):17327-17332.
9. Peterson D.S., Wellems T.E. EBL-1, a putative erythrocyte binding protein of Plasmodium falciparum, maps within a favored linkage group in two genetic crosses. Mol Biochem Parasitol. 2000;105(1):105-113.
10. Adams J.H., Sim B.K.L., Dolan S.A., Fang X., Kaslow D.C., Miller L.H. A family of erythrocyte binding proteins of malaria parasites. Proc Natl Acad Sci U S A. 1992;89(15):7085-7089.
11. Rayner J.C., Galinski M.R., Ingravallo P., Barnwell J.W. Two Plasmodium falciparum genes express merozoite proteins that are related to Plasmodium vivax and Plasmodium yoelii adhesive proteins involved in host cell selection and invasion. Proc Natl Acad Sci U S A. 2000;97(17):9648-9653. (Pubitemid 30650830)
12. Rayner J.C., Vargas-Serrato E., Huber C.S., Galinski M.R., Barnwell J.W. A Plasmodium falciparum homologue of Plasmodium vivax reticulocyte binding protein (PvRBP1) defines a trypsinresistant erythrocyte invasion pathway. J Exp Med. 2001;194(11):1571-1581 (Pubitemid 33126808)
13. Maier A.G., Duraisingh M.T., Reeder J.C., et al. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat Med. 2003;9(1):87-92. (Pubitemid 36098265)
14. Mayer D.C., Cofie J., Jiang L., et al. Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1. Proc Natl Acad Sci U S A. 2009;106(13):5348-5352.
15. Sim B.K., Chitnis C.E., Wasniowska K., Hadley T.J., Miller L.H. Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science. 1994;264(5167):1941-1944. (Pubitemid 24245642)
16. Reid K.B., Day A.J. Structure-function relationships of the complement components. Immunol Today. 1989;10(6):177-180. (Pubitemid 19133695)
17. Krych-Goldberg M., Atkinson J.P. Structurefunction relationships of complement receptor type 1. Immunol Rev. 2001;180:112-122. (Pubitemid 32475753)
18. Krych M., Hourcade D., Atkinson J.P. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. Proc Natl Acad Sci U S A. 1991;88(10):4353-4357. (Pubitemid 21914538)
19. Klickstein L.B., Bartow T.J., Miletic V., Rabson L.D., Smith J.A., Fearon D.T. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis. J Exp Med. 1988;168(5):1699-1717. (Pubitemid 19023257)
20. Birmingham D.J., Hebert L.A. CR1 and CR1-like: The primate immune adherence receptors. Immunol Rev. 2001;180:100-111. (Pubitemid 32472856)
21. Kalli K.R., Hsu P.H., Bartow T.J., et al. Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab′)2 chimeric complement inhibitor. J Exp Med. 1991;174(6):1451-1460.
22. Iida K., Nussenzweig V. Complement receptor is an inhibitor of the complement cascade. J Exp Med. 1981;153(5):1138-1150. (Pubitemid 11107583)
23. Krych-Goldberg M., Hauhart R.E., Subramanian V.B., et al. Decay accelerating activity of complement receptor type 1 (CD35). Two active sites are required for dissociating C5 convertases. J Biol Chem. 1999;274(44):31160- 31168.
24. Ross G.D., Lambris J.D., Cain J.A., Newman S.L. Generation of 3 different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity. J Immunol. 1982;129(5):2051-2060. (Pubitemid 12004368)
25. Medof M.E., Iida K., Mold C., Nussenzweig V. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med. 1982;156(6):1739-1754. (Pubitemid 13167418)
26. Kumaratilake L.M., Ferrante A. Opsonization and phagocytosis of Plasmodium falciparum merozoites measured by flow cytometry. Clin Diagn Lab Immunol. 2000;7(1):9-13. (Pubitemid 30051453)
27. Kumaratilake L.M., Ferrante A., Jaeger T., Rzepczyk C.M. Effects of cytokines, complement, and antibody on the neutrophil respiratory burst and phagocytic response to Plasmodium falciparum merozoites. Infect Immun. 1992;60(9):3731-3738.
28. Weisman H.F., Bartow T., Leppo M.K., et al. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 1990;249(4965):146-151.
29. Schmidt C.Q., Slingsby F.C., Richards A., Barlow P.N. Production of biologically active complement factor H in therapeutically useful quantities. Protein Expr Purif. 2011;76(2):254-263.
30. Nickells M., Hauhart R., Krych M., et al. Mapping epitopes for 20 monoclonal antibodies to CR1. Clin Exp Immunol. 1998;112(1):27-33. (Pubitemid 28157095)
31. Tham W.H., Wilson D.W., Reiling L., Chen L., Beeson J.G., Cowman A.F. Antibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytes. Infect Immun. 2009;77(6):2427-2435.
32. Triglia T., Duraisingh M.T., Good R.T., Cowman A.F. Reticulocyte-binding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum. Mol Microbiol. 2005;55(1):162-174. (Pubitemid 40127893)
33. Stubbs J., Simpson K.M., Triglia T., et al. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science. 2005;309(5739):1384-1387. (Pubitemid 41209367)
34. Duraisingh M.T., Maier A.G., Triglia T., Cowman A.F. Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc Natl Acad Sci U S A. 2003;100:4796-4801. (Pubitemid 36457808)
35. Persson K.E., McCallum F.J., Reiling L., et al. Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies. J Clin Invest. 2008;118(1):342-351.
36. Harris C.L., Pettigrew D.M., Lea S.M., Morgan B.P. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay. J Immunol. 2007;178(1):352-359. (Pubitemid 46039662)
37. Wu J., Wu Y.Q., Ricklin D., Janssen B.J., Lambris J.D., Gros P. Structure of complement fragment C3bfactor H and implications for host protection by complement regulators. Nat Immunol. 2009;10(7):728-733.
38. Duraisingh M.T., Triglia T., Ralph S.A., et al. Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. EMBO J. 2003;22(5):1047-1057. (Pubitemid 36313589)
39. Maier A.G., Baum J., Smith B., Conway D.J., Cowman A.F. Polymorphisms in erythrocyte binding antigens 140 and 181 affect function and binding but not receptor specificity in. Plasmodium falciparum. Infect Immun. 2009;77(4):1689-1699.
40. Xiang L., Rundles J.R., Hamilton D.R., Wilson J.G. Quantitative alleles of CR1: Coding sequence analysis and comparison of haplotypes in two ethnic groups. J Immunol. 1999;163(9):4939-4945. (Pubitemid 29501260)
41. Lobo C.A., De Frazao K., Rodriguez M., Reid M., Zalis M., Lustigman S. Invasion profiles of Brazilian field isolates of Plasmodium falciparum: Phenotypic and genotypic analyses. Infect Immun. 2004;72(10):5886-5891 (Pubitemid 39303701)
42. Deans A.M., Nery S., Conway D.J., Kai O., Marsh K., Rowe J.A. Invasion pathways and malaria severity in Kenyan Plasmodium falciparum clinical isolates. Infect Immun. 2007;75(6):3014-3020. (Pubitemid 46870185)
43. Gomez-Escobar N., Amambua-Ngwa A., Walther M., Okebe J., Ebonyi A., Conway D.J. Erythrocyte invasion and merozoite ligand gene expression in severe and mild Plasmodium falciparum malaria. J Infect Dis. 2010;201(3):444-452.
44. Bei A.K., Membi C.D., Rayner J.C., et al. Variant merozoite protein expression is associated with erythrocyte invasion phenotypes in Plasmodium falciparum isolates from Tanzania. Mol Biochem Parasitol. 2007;153(1):66-71. (Pubitemid 46522536)
45. Okoyeh J.N., Pillai C.R., Chitnis C.E. Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A. Infect Immun. 1999;67(11):5784-5791. (Pubitemid 29508099)
46. Awandare G.A., Spadafora C., Moch J.K., Dutta S., Haynes J.D., Stoute J.A. Plasmodium falciparum field isolates use complement receptor 1 (CR1) as a receptor for invasion of erythrocytes. Mol Biochem Parasitol. 2011;177(1):57-60.
47. Rowe J.A., Moulds J.M., Newbold C.I., Miller LH. P. falciparum rosetting mediated by a parasitevariant erythrocyte membrane protein and complement-receptor 1. Nature. 1997;388(6639):292-295. (Pubitemid 27317975)
48. Rowe J.A., Rogerson S.J., Raza A., et al. Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. J Immunol. 2000;165(11):6341-6346.
49. Gilson P.R., Crabb B.S. Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Int J Parasitol. 2009;39(1):91-96.
50. Glodek A.M., Mirchev R., Golan D.E., et al. Ligation of complement receptor 1 increases erythrocyte membrane deformability. Blood. 2010;116(26):6063-6071.